TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05557448: An Exploratory Study to Evaluate the Efficacy and Safety of TYNADOTE® Combined N-acetylcysteine in the Treatment of Acetaminophen Overdose

Sponsor: Sinew Pharma Inc. · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 24 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$352,800

Rescue Site Savings

+$235,200

Unlock Full NCT05557448 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05557448 Rescue Dossier →